Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
25.24
+0.87 (3.57%)
At close: Jun 26, 2026, 4:00 PM EDT
25.82
+0.58 (2.30%)
After-hours: Jun 26, 2026, 4:57 PM EDT
Pacira BioSciences Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Pacira BioSciences stock have an average target of 29.67, with a low estimate of 23 and a high estimate of 38. The average target predicts an increase of 17.55% from the current stock price of 25.24.
Analyst Consensus: Buy
* Price targets were last updated on May 14, 2026.
Analyst Ratings
The average analyst rating for Pacira BioSciences stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $25 | Hold | Maintains | $25 | -0.95% | May 14, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $38 | Buy | Reiterates | $38 | +50.55% | May 4, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 1, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $22 → $24 | Hold | Maintains | $22 → $24 | -4.91% | May 1, 2026 |
| Needham | Needham | Buy Maintains $30 → $32 | Buy | Maintains | $30 → $32 | +26.78% | May 1, 2026 |
Financial Forecast
Revenue This Year
767.79M
from 726.41M
Increased by 5.70%
Revenue Next Year
831.29M
from 767.79M
Increased by 8.27%
EPS This Year
2.88
from 2.65
Increased by 8.57%
EPS Next Year
3.65
from 2.88
Increased by 26.79%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 769.0M | 842.7M | |
| Avg | 767.8M | 831.3M | |
| Low | 766.5M | 809.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.9% | 9.8% | |
| Avg | 5.7% | 8.3% | |
| Low | 5.5% | 5.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.98 | 4.01 | |
| Avg | 2.88 | 3.65 | |
| Low | 2.74 | 3.18 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 12.5% | 39.4% | |
| Avg | 8.6% | 26.8% | |
| Low | 3.3% | 10.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.